LAB Standard Biotools Inc
Company Analysis
Latest News
🔴 Standard Biotools is trading 5.4% down today with no company-specific catalyst identified
Standard Biotools is trading 5.37% lower at $0.60, with no company-specific announcement identified for October 23. - Its latest listed release was the October...
🟢 Standard Biotools is trading 9.18% up in pre-market with no clear catalyst identified
Standard Biotools is trading 9.18% up in pre-market at $0.71, versus its October 21 close of $0.65; no clear company-specific catalyst has been identified. -...
🟢 Standard Biotools is trading 5% up; catalyst remains unclear
Standard Biotools is trading 5.36% higher at $0.67 on October 15, 2026, with no clear catalyst identified. - No new company-specific announcement or reliable...
🔴 Standard Biotools is trading 5% down on October 12, 2026, with no clear catalyst identified
Standard Biotools is trading at $0.65, down 5.03%, with no specific catalyst established for the October 12 decline. - The latest identified release was an...
🔴 Standard Biotools is trading 5% down — no clear catalyst identified
Standard Biotools is trading at $0.64, down 5.26%, as the cause of its October 8, 2026 decline remains uncertain. - No clear company-specific announcement...
🔴 Standard Biotools is trading 5.6% down
Standard Biotools is trading 5.6% lower at $0.72, with no clear company-specific catalyst identified. - The price is down from the October 5 close of $0.76;...
🟢 Standard Biotools is trading 5% up today after Microfluidics sale agreement with ARCHIMED
Standard Biotools is trading at $0.80, up 5.06%, following its October 5 announcement of an agreement to sell its Microfluidics business to ARCHIMED. - The...
Standard BioTools Announces Definitive Agreement to Sell Microfluidics Business to ARCHIMED
Standard BioTools Inc. has entered into a definitive agreement to sell its Microfluidics business segment to ARCHIMED, an investment firm focused on the...
🟢 Standard Biotools is trading 6.4% up
Standard Biotools is trading at $0.79, up 6.36%, with no clear company announcement identified to explain the October 5 move. - The latest company news...
🔴 Standard Biotools is trading 5.7% down in after-hours trading
Standard Biotools is trading 5.7% lower at $0.70 after the October 2, 2026 regular-session close of $0.74; no clear company-specific announcement explaining...
Standard BioTools Enters $5.5M Agreement to Sell Mass Cytometry Business
Standard BioTools Inc. (LAB) has entered into a definitive agreement to sell its mass cytometry business to Element Biosystems, LLC, a subsidiary of GMT...
🔴 Standard Biotools is trading 5% down today with no clear catalyst
Standard Biotools is trading 5.04% down at $0.73, with no fresh company announcement identified to explain the September 21 decline. - This reverses the...
🟢 Standard Biotools is trading 5.2% up today following the Federal Reserve decision and improved sentiment
Standard Biotools is trading 5.2% higher at $0.75 amid broad risk-on sentiment. - Major indices are higher, with the S&P 500 up 0.94% and Nasdaq Composite up...
🟢 Standard Biotools is trading 5% up today amid broader market gains
Standard Biotools is trading at $0.73, up +5.10% on September 16, 2026, alongside a constructive broader market backdrop. - The Nasdaq rose 0.64%, while the...
🔴 Standard Biotools is trading 5% down today amid broader risk-off trading
Standard Biotools is trading 5% down at $0.69 after opening-market selling on September 10, 2026, amid broader risk-off trading. - No clear company-specific...
🟢 Standard Biotools is trading 5% up today on unexplained stock-specific buying
Standard Biotools is trading 5.10% up now at $0.73, with the move appearing to reflect unexplained, stock-specific buying. - No clear company-specific...
🟢 Standard Biotools is trading 5.9% up today — catalyst remains unclear
Standard Biotools is trading at $0.73, 5.9% up, continuing a modest rebound from $0.69 on September 4, 2026, while the catalyst remains unclear. - No new...
🟢 Standard Biotools is trading 6.84% up today in after-hours trading, likely supported by broader market strength
Standard Biotools is trading 6.84% up now at $0.72 in after-hours trading, likely supported by broader market strength. - No fresh company-specific...
🟢 Standard Biotools is trading 5.6% up today amid healthcare-sector gains on strong medical-device earnings
Standard Biotools is trading 5.6% up at $0.69, with broader healthcare-sector gains on strong medical-device earnings supporting sentiment. - No fresh...
🟢 Standard Biotools is trading 7.65% up in pre-market amid broader risk-on sentiment
Standard Biotools is trading 7.65% up at $0.70 in pre-market, most likely reflecting broader risk-on sentiment. - No fresh company-specific announcement was...